Epacria Capital Partners, LLC Clear Point Neuro, Inc. Transaction History
Epacria Capital Partners, LLC
- $123 Billion
- Q3 2025
A detailed history of Epacria Capital Partners, LLC transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Epacria Capital Partners, LLC holds 11,729 shares of CLPT stock, worth $181,682. This represents 0.21% of its overall portfolio holdings.
Number of Shares
11,729
Previous 11,729
-0.0%
Holding current value
$181,682
Previous $140 Million
82.5%
% of portfolio
0.21%
Previous 0.12%
Shares
1 transactions
Others Institutions Holding CLPT
# of Institutions
114Shares Held
8.38MCall Options Held
437KPut Options Held
199K-
Vanguard Group Inc Valley Forge, PA1.5MShares$23.2 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA656KShares$10.2 Million0.0% of portfolio
-
State Street Corp Boston, MA483KShares$7.48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$5.68 Million0.0% of portfolio
-
Ubs Group Ag361KShares$5.59 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $379M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...